Anxiety and Metabolic Disorders: The Role of Botanicals
- PMID: 36826013
- PMCID: PMC9954866
- DOI: 10.3390/cimb45020068
Anxiety and Metabolic Disorders: The Role of Botanicals
Abstract
Anxiety and anxiety-related disorders are becoming more evident every day, affecting an increasing number of people around the world. Metabolic disorders are often associated with anxiety. Furthermore, anxiety branches into metabolic disorders by playing multiple roles as a cofactor, symptom, and comorbidity. Taken together, these considerations open the possibility of integrating the therapy of metabolic disorders with specific drugs for anxiety control. However, anxiolytic compounds often cause disabling effects in patients. The main goal could be to combine therapeutic protocols with compounds capable of reducing side effects while performing multiple beneficial effects. In this article we propose a group of bioactive ingredients called botanicals as a healthy supplement for the treatment of metabolic disorders related to anxiety.
Keywords: anxiety; botanicals; bud derivates; metabolic disorders; nutraceuticals.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Botanicals for mood disorders with a focus on epilepsy.Epilepsy Behav. 2015 Nov;52(Pt B):319-28. doi: 10.1016/j.yebeh.2015.08.019. Epub 2015 Sep 26. Epilepsy Behav. 2015. PMID: 26409901 Review.
-
Use of an Animal Model to Evaluate Anxiolytic Effects of Dietary Supplementation with Tilia tomentosa Moench Bud Extracts.Nutrients. 2020 Oct 29;12(11):3328. doi: 10.3390/nu12113328. Nutrients. 2020. PMID: 33138077 Free PMC article.
-
Pharmacogenomic assessment of herbal drugs in affective disorders.Biomed Pharmacother. 2019 Jan;109:1148-1162. doi: 10.1016/j.biopha.2018.10.135. Epub 2018 Nov 6. Biomed Pharmacother. 2019. PMID: 30551365 Review.
-
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.World J Biol Psychiatry. 2022 Jul;23(6):424-455. doi: 10.1080/15622975.2021.2013041. Epub 2022 Mar 21. World J Biol Psychiatry. 2022. PMID: 35311615
-
Nip it in the Bud: Botanicals for Anxiety - a Practical Prescriber's Guide.Curr Psychiatry Rep. 2022 Oct;24(10):503-508. doi: 10.1007/s11920-022-01365-w. Curr Psychiatry Rep. 2022. PMID: 36048322 Review.
Cited by
-
Editorial for the Special Issue "Bioactive Compounds of Natural Products on Metabolic Disorders and Complications".Curr Issues Mol Biol. 2023 Jul 5;45(7):5706-5707. doi: 10.3390/cimb45070359. Curr Issues Mol Biol. 2023. PMID: 37504275 Free PMC article.
-
Gingerols and Shogaols of Zingiber officinale var. sunti Valeton as Potential Allosteric Agonists of Human GABAA Receptor by in silico Pharmacology Approach.J Exp Pharmacol. 2025 Jun 17;17:359-374. doi: 10.2147/JEP.S524890. eCollection 2025. J Exp Pharmacol. 2025. PMID: 40547511 Free PMC article.
-
Unveiling Niaprazine's Potential: Behavioral Insights into a Re-Emerging Anxiolytic Agent.Biomedicines. 2024 Sep 12;12(9):2087. doi: 10.3390/biomedicines12092087. Biomedicines. 2024. PMID: 39335600 Free PMC article.
References
-
- Boggia R., Zunin P., Turrini F. Functional Foods and Food Supplements. Appl. Sci. 2020;10:8538. doi: 10.3390/app10238538. - DOI
-
- Colombo F., Restani P., Biella S., Di Lorenzo C. Botanicals in Functional Foods and Food Supplements: Tradition, Efficacy and Regulatory Aspects. Appl. Sci. 2020;10:2387. doi: 10.3390/app10072387. - DOI
-
- Schieber A. Botanicals—Challenges Abound, Solutions in Sight? Curr. Opin. Food Sci. 2020;32:144–148. doi: 10.1016/j.cofs.2020.07.003. - DOI
LinkOut - more resources
Full Text Sources